National Institute of Arthritis and Musculoskeletal and Skin Diseases Clinical Studies Management and Support
国家关节炎、肌肉骨骼和皮肤疾病研究所临床研究管理和支持
基本信息
- 批准号:9553427
- 负责人:
- 金额:$ 166.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdherenceArthritisBiometryClinical ResearchClinical TrialsConsultationsContractsDataData QualityDevelopmentEnsureFundingGood Clinical PracticeGuidelinesInstitutesLogisticsMonitorMusculoskeletal DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPoliciesResearch PersonnelSafetyServicesSupport ContractsSystemTrainingclinical research sitemeetingsoperationresearch studyskin disorder
项目摘要
The Assessments and Assistance for National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Clinical Studies contract supports the NIAMS with the oversight and management of its clinical research studies and clinical trials. This contract supports clinical trials and clinical research in arthritis and musculoskeletal and skin diseases. The services will include the necessary operations needed to execute clinical research studies and clinical trials from study inception to completion. Examples of these services include but are not limited to; clinical study document development and review; data and safety monitoring committee management and support; logistical and executive secretarial support for meetings; clinical site monitoring and study assessment; biostatistical review and consultation; regulatory support and consultation; Good Clinical Practice training for NIAMS staff and Investigators; and the development of electronic systems for managing clinical study information/data. The executive secretarial/logistical functions for the management of committees providing data and safety monitoring oversight to NIAMS funded clinical studies and clinical trials. In addition, this contract effort provides assistance with the conduct of clinical research to ensure data quality and adherence to good clinical practice, and Federal guidelines and policies.
国家关节炎、肌肉骨骼和皮肤疾病研究所(NIAMS)临床研究评估和援助合同支持NIAMS的临床研究和临床试验的监督和管理。该合同支持关节炎、肌肉骨骼和皮肤疾病的临床试验和临床研究。这些服务将包括从研究开始到完成执行临床研究和临床试验所需的必要操作。这些服务的示例包括但不限于:临床研究文件的开发和审查;数据和安全监测委员会的管理和支持;为会议提供后勤和执行秘书支助;临床现场监测和研究评估;生物统计审查和咨询;监管支持和咨询;对NIAMS员工和调查员进行良好临床操作规范培训;以及用于管理临床研究信息/数据的电子系统的开发。执行秘书/后勤职能,负责管理为NIAMS资助的临床研究和临床试验提供数据和安全监测监督的委员会。此外,该合同还为临床研究的开展提供协助,以确保数据质量并遵守良好的临床实践和联邦指导方针和政策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHY DIMEO其他文献
KATHY DIMEO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHY DIMEO', 18)}}的其他基金
NIAMS Clinical Studies Management and Support
NIAMS 临床研究管理和支持
- 批准号:
9357751 - 财政年份:2016
- 资助金额:
$ 166.79万 - 项目类别:
National Institute of Arthritis and Musculoskeletal and Skin Diseases Clinical Studies Management and Support
国家关节炎、肌肉骨骼和皮肤疾病研究所临床研究管理和支持
- 批准号:
10006481 - 财政年份:2016
- 资助金额:
$ 166.79万 - 项目类别:
National Institute of Arthritis and Musculoskeletal and Skin Diseases Clinical Studies Management and Support
国家关节炎、肌肉骨骼和皮肤疾病研究所临床研究管理和支持
- 批准号:
10252738 - 财政年份:2016
- 资助金额:
$ 166.79万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 166.79万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 166.79万 - 项目类别:
Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
- 批准号:
10068495 - 财政年份:2024
- 资助金额:
$ 166.79万 - 项目类别:
Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 166.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
- 批准号:
24K19850 - 财政年份:2024
- 资助金额:
$ 166.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 166.79万 - 项目类别:
Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
- 批准号:
489316 - 财政年份:2023
- 资助金额:
$ 166.79万 - 项目类别:
Operating Grants
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 166.79万 - 项目类别:
Fellowship
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
- 批准号:
23K14987 - 财政年份:2023
- 资助金额:
$ 166.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 166.79万 - 项目类别: